The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...

Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring ...

Big pharma’s pushing for PBS funding, and it’s kickstarting a shift to healthier snacks, smaller portions, and more ...

Infant mortality in the U.S. has increased by 7% since the 2022 Dobbs v. Jackson U.S. Supreme Court decision overturned the ...

Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...

A larger body doesn’t necessarily mean you have ‘clinical obesity’, according to a proposed new definition of the disease.

One life science executive posed a provocative question about that human centrality at an event organized by consulting firm ... the healthcare industry, a Novo Nordisk executive —Thomas ...

A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated with empathy – offers promise for addressing a key symptom among patients ...

Pharmapack wrapped up last week with two full days of new product innovation, networking, and informative talks, sessions, ...

There has been a lot of discussion in Ghana's legal and political circles about Attorney General Dr. Dominic Ayine's recent ...

The microbial ecosystems within our mouths may affect our cognitive function as we age, according to a study. Interventions such as prebiotics, including dietary nitrate, have potential for delaying ...